铁死亡:黑色素瘤治疗的可靶向脆弱点
本综述围绕铁死亡的分子机制及其在黑色素瘤中的调控展开,探讨黑色素瘤表型可塑性、代谢状态、基因组与表观遗传改变如何影响铁死亡,并分析铁死亡在免疫细胞中的作用及治疗潜力,提出未来研究需回答的关键问题。
要点
- 铁死亡是铁依赖的调节性细胞死亡,由脂质过氧化物过度积累驱动。
- 黑色素瘤生物学特征(表型可塑性、代谢、基因组与表观遗传)影响铁死亡调控。
- 临床前模型中铁死亡是有前景的治疗策略。
核心结论
- 铁死亡在临床前黑色素瘤模型中是有前景的治疗策略,深入理解其调控格局可为开发有效治疗提供基础。
研究设计与样本
- 综述,检索范围与纳入文献数量原文未报告。
主要发现
- 免疫治疗与靶向治疗虽革新黑色素瘤治疗,但多数患者未能获得持久缓解。
- 黑色素瘤具高突变负荷、治疗成功率有限与预后差的特点。
- 黑色素瘤的表型可塑性、代谢状态、基因组改变与表观遗传变化参与铁死亡调控。
- 免疫细胞中铁死亡的作用与机制复杂,可能影响治疗策略。
临床怎么用
- 把握铁死亡作为黑色素瘤潜在治疗靶点的方向,关注患者黑色素瘤生物学特征对铁死亡调控的影响。
局限性
- 本文为综述,原文未报告具体研究样本量、效应值或统计学结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Melanoma is a devastating form of skin cancer characterized by a high mutational burden, limited treatment success, and dismal prognosis. Although immunotherapy and targeted therapies have significantly revolutionized melanoma treatment, the majority of patients fail to achieve durable responses, highlighting the urgent need for novel therapeutic strategies. Ferroptosis, an iron-dependent form of regulated cell death driven by the overwhelming accumulation of lipid peroxides, has emerged as a promising therapeutic approach in preclinical melanoma models. A deeper understanding of the ferroptosis landscape in melanoma based on its biology characteristics, including phenotypic plasticity, metabolic state, genomic alterations, and epigenetic changes, as well as the complex role and mechanisms of ferroptosis in immune cells could provide a foundation for developing effective treatments. In this review, we outline the molecular mechanisms of ferroptosis, decipher the role of melanoma biology in ferroptosis regulation, reveal the therapeutic potential of ferroptosis in melanoma, and discuss the pressing questions that should guide future investigations into ferroptosis in melanoma.
引用
- Meng Y, Zhou Q, Dian Y, et al. Ferroptosis: A Targetable Vulnerability for Melanoma Treatment. J Invest Dermatol. 2025. PMID: 39797894. doi:10.1016/j.jid.2024.11.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。